EP
DRNA
Eversept Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-128,905
| Closed | -$3.27M | – | 74 |
|
2020
Q2 | $3.27M | Buy |
128,905
+69,131
| +116% | +$1.76M | 0.45% | 33 |
|
2020
Q1 | $1.1M | Buy |
59,774
+41,100
| +220% | +$755K | 0.27% | 39 |
|
2019
Q4 | $411K | Sell |
18,674
-22,400
| -55% | -$493K | 0.07% | 66 |
|
2019
Q3 | $590K | Hold |
41,074
| – | – | 0.18% | 49 |
|
2019
Q2 | $647K | Hold |
41,074
| – | – | 0.18% | 50 |
|
2019
Q1 | $602K | Hold |
41,074
| – | – | 0.18% | 42 |
|
2018
Q4 | $439K | Sell |
41,074
-10,000
| -20% | -$107K | 0.24% | 44 |
|
2018
Q3 | $779K | Sell |
51,074
-33,926
| -40% | -$518K | 0.34% | 39 |
|
2018
Q2 | $1.04M | Buy |
+85,000
| New | +$1.04M | 0.48% | 41 |
|